Kathryn Thrailkill
Physician · University of Kentucky College of Medicine
Credentials: · · ·
History
Pediatric Endocrinology
Pediatrics
Research
Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues
Review · American Journal of Physiology-Endocrinology and Metabolism · 2005 · First of 5 authors · Corresponding · 368 citations
Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy
Review · Endocrine · 2009 · First of 3 authors · Corresponding · 149 citations
Endocrinology · 1995 · First of 6 authors · 133 citations
53 papers
9 papers
- SK
7 papers
- SH
6 papers
5 papers
- JA
5 papers
- PM
4 papers
4 papers
Grants
- 2016–2019
Effects of Sodium-Dependent Glucose Co-Transporter 2 Inhibition on Bone.
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R21
Contact PI · $387.1K · University of Kentucky
- 2002–2008
Matrix Metalloproteinases and Diabetic Nephropathy
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $1.3M · Arkansas Children's Hospital Res Inst
- 2004–2007
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $132K · Univ of Arkansas for Med Scis
- 1997–1999
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $146.3K · University of Kentucky
Clinical trials
- 2005–2011
Preservation of Pancreatic Beta Cell Function Through Insulin Pump Therapy
Principal investigator · Completed
Arkansas Children's Hospital Research Institute
- 2003–2008
Matrix Metalloproteinases and Diabetic Nephropathy
Principal investigator · Completed
Arkansas Children's Hospital Research Institute